Cleared Traditional

K904816 - THYROXINE MONOCLONAL ANTIBODY SOLID PHASE RADIOIMM (FDA 510(k) Clearance)

Jan 1991
Decision
85d
Days
Class 2
Risk

K904816 is an FDA 510(k) clearance for the THYROXINE MONOCLONAL ANTIBODY SOLID PHASE RADIOIMM. This device is classified as a Radioimmunoassay, Total Thyroxine (Class II - Special Controls, product code CDX).

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on January 17, 1991, 85 days after receiving the submission on October 24, 1990.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.1700.

Submission Details

510(k) Number K904816 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 1990
Decision Date January 17, 1991
Days to Decision 85 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code CDX — Radioimmunoassay, Total Thyroxine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1700